Denali Therapeutics Inc. (DNLI) Gained 5.88% or 1.09 To Price $19.71 On Tuesday

Denali Therapeutics Inc. (DNLI) gained 5.88% or 1.09 to $19.71. It is approximately 87755 shares traded, which is 28.14% compare to the average total volume 311812. The market cap of DNLI is $1.86 billion. The year to date change is 15.44%. The 52 week price range is from $14.72 to $25.79. Price of DNLI have changed -5.10% during last week. It have changed -13.54% over last month, 8.89% over last 3 months, -13.19% over last 6 months and -13.19% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 20.92. It is 6.14% above current price. The 52-week High is 25.79. It is 30.85% from the current price. The 52-week Low is 14.72. It is -25.32% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DNLI is 12.4 on 2018-03-29. Short % to float is 5.20%. There are some statistics of DNLI. It is has market cap $1.86 billion. The share outstanding is 94.43 million. The average volume is 311812. The percent of top 15 Institution holding is 85.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -47.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -23.27%.


Share this post